[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Epidemiology](https://durgical.com/en/epidemiology/) › [Screening](https://durgical.com/en/epidemiology/areas/screening/) › Cancer screening in adults by site: what Colombia offers

# Cancer screening in adults by site: what Colombia offers

- Concept

Only a few cancers have a test that saves lives in healthy people. Knowing which ones, from what age and what a positive leads to is everyday practice.

Updated Nov 19, 2026

**See it in 3D:** [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/) · [Prostate](https://durgical.com/en/anatomy/prostate/) · [Sigmoid colon](https://durgical.com/en/anatomy/sigmoid-colon/) · [Stomach](https://durgical.com/en/anatomy/stomach/)

## Key points

- [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/): cytology every 3 years after a negative (25–29); [HPV DNA test](https://durgical.com/en/nursing/taking-a-cervical-cytology-or-hpv-sample-and-assisting-the-pelvic-examination/) every 5 years (30–65); visual inspection and immediate treatment (30–50) in hard-to-reach areas.
- Breast: clinical breast exam at least yearly from 40; two-view mammogram every 2 years from 50 to 69.
- Colorectal: faecal immunochemical test (FIT) every 2 years, or colonoscopy every 10 years where available, from 50 to 75; a positive FIT leads to colonoscopy.
- [Prostate](https://durgical.com/en/anatomy/prostate/): PSA plus digital rectal exam from 50 to 75, no more often than every 5 years, only after explaining benefits and harms.
- Lung: low-dose CT suggested (weak) for 55–74 with at least 30 pack-years; not part of [Res. 3280](https://durgical.com/en/family-medicine/the-periodic-health-exam-in-adults-and-older-adults-under-the-rias/).
- [Stomach](https://durgical.com/en/anatomy/stomach/) and skin: no population screening in Colombia; alarm symptoms and the examination lead to endoscopy or biopsy.

On this page

- The basics Key points
- What it is
- How to think about it
- Worked example
- Average-risk adult screening by site in Colombia (Res. 3280 de 2018 unless stated)
- Markers
- In practice
- Common pitfalls
- Common traps
- Memory aid
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

In Colombia, Resolución 3280 de 2018 (modified by Resolución 276 de 2019) sets screening for four cancers inside the health promotion and maintenance pathway: cervix and colorectum (organised, population screening), breast, and prostate (opportunistic, only after an informed decision). Lung screening with low-dose CT is suggested for heavy smokers by a 2014 MinSalud clinical practice guideline, but it is not a pathway intervention and there is no national programme. Stomach and skin have no population screening: they depend on alarm symptoms, risk groups and the clinical examination. Every positive screen leads to a confirmatory test, never straight to treatment, and people with symptoms or high risk leave the average-risk schedule.

## How to think about it

Screens come in two kinds. Some find a precursor and remove it (cervical lesions, colorectal adenomas), so they prevent cancer and the [incidence](https://durgical.com/en/epidemiology/incidence/) falls. Others only find cancer earlier (breast, prostate, lung), so only mortality can fall and [overdiagnosis](https://durgical.com/en/epidemiology/overdiagnosis/) is the price. The more a test finds disease that would never have harmed, the more the decision belongs to the person.

## Worked example

- Made-up couple at a routine adult visit: Marta, 56, and Jorge, 62, who has smoked a pack a day for 40 years (40 pack-years).
- Marta is due an HPV DNA test (negative: next in 5 years), a mammogram every 2 years, a yearly breast exam and a FIT every 2 years.
- Jorge is due a FIT every 2 years and is offered PSA with a rectal exam after a talk on benefits and harms; first of all he is helped to stop smoking.
- His smoking (40 pack-years, age 62) fits the 2014 guideline's low-dose CT criteria, but it is not a pathway benefit, so it is discussed, not ordered by default.
- The PSA talk in numbers (USPSTF 2018, men 55–69, per 1,000 screened over about 13 years): about 1.3 [prostate cancer](https://durgical.com/en/conditions/prostate-cancer/) deaths and 3 metastatic cases avoided.
- The other side: about 240 have a positive PSA, 220 a biopsy, 100 a diagnosis (20–50% of them overdiagnosed); about 50 sexual dysfunction, 15 incontinence.
- Reading: about 1 death avoided against dozens of men harmed per 1,000 is a choice of values, which is why the resolution asks for an informed decision.
- Marta's FIT comes back positive: not a cancer diagnosis but a priority colonoscopy, where an adenoma found can be removed and the cancer prevented.

## Average-risk adult screening by site in Colombia (Res. 3280 de 2018 unless stated)

| Site | Who | Test and interval | A positive leads to | Status in Colombia |
| --- | --- | --- | --- | --- |
| Cervix | Women 25–29 (cytology) and 30–65 (HPV DNA) | Cytology every 3 years after a negative; HPV DNA every 5 years; 30–50 in dispersed areas: visual inspection with acetic acid and Lugol | HPV positive: triage cytology from the same visit, then [colposcopy](https://durgical.com/en/obstetrics-gynaecology/after-an-abnormal-cervical-screening-result-triage-cytology-categories-and-colpo/) and biopsy; visual inspection positive: treatment in the same visit | Organised, mandatory |
| Breast | Women from 40 (exam) and 50–69 (mammogram) | Clinical breast exam at least yearly; two-view mammogram every 2 years | BI-RADS 0: more imaging; 3: follow-up on the [breast cancer](https://durgical.com/en/conditions/breast-cancer/) route; 4–5: active recall and biopsy | Organised |
| Colorectum | Men and women 50–75 at average risk | FIT (one sample) every 2 years, or colonoscopy every 10 years where available | Active recall and colonoscopy with biopsy, with priority | Organised, population |
| Prostate | Men 50–75; from 40 with family history, risk factors or findings: risk assessment | PSA plus digital rectal exam, at intervals of no less than 5 years | Raised PSA with normal exam: repeat within 6 months, urology if still raised; abnormal exam: urology within 4 weeks | Opportunistic, informed shared decision |
| Lung | 55–74, at least 30 pack-years, smoking now or quit under 15 years ago | Low-dose CT yearly; stop after 3 consecutive negatives | Nodule work-up by a multidisciplinary team | MinSalud guideline 2014 (weak suggestion); not in Res. 3280 |
| Stomach | No average-risk screening | None; prompt endoscopy for alarm symptoms (weight loss, dysphagia, bleeding, anaemia) | Biopsy | No population programme |
| Skin | No population screening | Skin inspected at the routine adult assessment (sun damage, actinic keratoses) | Biopsy of a suspicious lesion | No separate programme |

## Markers

- HPV DNA test
- Mammography
- FIT
- PSA
- Low-dose CT

## In practice

- Symptoms are not screening: a woman with a [breast lump](https://durgical.com/en/obstetrics-gynaecology/a-breast-lump-or-nipple-discharge-approach/) or a man with rectal bleeding gets a diagnostic work-up at any age, outside the schedule.
- Higher risk leaves the average schedule: family history, hereditary syndromes, inflammatory bowel disease or previous polyps go to the cancer risk pathway, with earlier and more frequent tests.
- Screening also stops: cervix at 65 if HPV tests in the past 5 years were negative; mammography at 69; colorectal and prostate at 75.
- [Gastric cancer](https://durgical.com/en/conditions/gastric-cancer/) is a leading cause of cancer death in parts of Colombia, such as the Andean south, yet healthy adults are not screened by endoscopy: alarm symptoms lead to prompt endoscopy.
- In smokers, stopping smoking does more than any scan, and a negative low-dose CT is not permission to keep smoking.

## Common pitfalls

- Screening a person who has symptoms instead of investigating them.
- Ordering the test and never acting on the result: Res. 3280 requires active recall of everyone with a positive.
- Using tumour markers such as CEA or [CA-125](https://durgical.com/en/biochemistry/topics/ca-125/) as screening tests: they have no screening role in average-risk adults.
- Testing for HPV before 30: infections are common and clear on their own at that age, so positives mostly mean transient infection.

## Common traps

- **PSA screening is a routine test like a mammogram**: Res. 3280 makes it opportunistic and conditional on an informed, shared decision, because its benefit is small and overdiagnosis is common
- **A positive FIT or HPV test means cancer**: it is a reason for the confirmatory step (colonoscopy, or triage cytology and colposcopy), and most positives are not cancer
- **Colombia screens heavy smokers with low-dose CT through the [RIAS](https://durgical.com/en/epidemiology/comprehensive-health-care-pathways/)**: the 2014 MinSalud guideline suggests offering it, but it is not a pathway intervention and there is no national programme
- **Because gastric cancer is common in Colombia, healthy adults get screening endoscopies**: there is no population programme, and endoscopy is for alarm symptoms or defined risk
- **Every screening test prevents cancer**: only screens that remove precursors (cervix, colorectum) lower incidence; the others find cancer earlier and lower only mortality

## Memory aid

Two that prevent (cervix, colon), three that find early (breast, prostate, lung).

## Test yourself

Think of the answer, then tap the question to see it.

## Why can cervical and colorectal screening lower the number of new cancers, while mammography cannot?

They find precursors (high-grade cervical lesions, adenomas) that are removed before they become cancer; mammography finds cancers that already exist, so it can only lower mortality.

## A 58-year-old man asks for a PSA test. What does Res. 3280 require before it is ordered?

An explanation of its potential benefits and harms and an agreed, informed decision; then PSA with a digital rectal exam, at intervals of no less than 5 years.

## A 52-year-old woman's FIT is positive. What happens next?

She is actively contacted and given a priority colonoscopy (with biopsy if needed); the FIT only flags higher probability, it does not diagnose cancer.

## A 63-year-old who smoked 35 pack-years and quit 5 years ago asks about lung screening. What is the Colombian position?

The 2014 MinSalud guideline suggests (weak recommendation) offering yearly low-dose CT to people like him after explaining benefits and risks, but it is not a Res. 3280 pathway intervention and there is no national programme.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/epidemiology/cancer-screening-in-adults-by-site-what-colombia-offers/)

## Elsewhere in DurgiPedia

- [Cervical cancer screening with HPV testing in Colombia](https://durgical.com/en/obstetrics-gynaecology/cervical-cancer-screening-with-hpv-testing-in-colombia/)
- [Breast cancer screening in Colombia](https://durgical.com/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/)
- [Prostate-specific antigen (PSA)](https://durgical.com/en/biochemistry/topics/prostate-specific-antigen/)
- [Mammography and breast ultrasound: BI-RADS in plain words](https://durgical.com/en/radiology/mammography-and-breast-ultrasound-bi-rads-in-plain-words/)
- [Checking a mole and the three skin cancers](https://durgical.com/en/dermatology/checking-a-mole-and-the-three-skin-cancers/)
- [Melanoma on palms, soles and nails](https://durgical.com/en/dermatology/melanoma-on-palms-soles-and-nails/)

## Connections

## See it in 3D 4

The structures of Durgical's 3D anatomy where it is found.

- [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/)
- [Prostate](https://durgical.com/en/anatomy/prostate/)
- [Sigmoid colon](https://durgical.com/en/anatomy/sigmoid-colon/)
- [Stomach](https://durgical.com/en/anatomy/stomach/)

## Related 7

- [Principles of screening](https://durgical.com/en/epidemiology/principles-of-screening/)
- [Overdiagnosis](https://durgical.com/en/epidemiology/overdiagnosis/)
- [Lead-time bias](https://durgical.com/en/epidemiology/lead-time-bias/)
- [Length-time bias](https://durgical.com/en/epidemiology/length-time-bias/)
- [Evaluating a screening programme](https://durgical.com/en/epidemiology/evaluating-a-screening-programme/)
- [Comprehensive health care pathways (RIAS)](https://durgical.com/en/epidemiology/comprehensive-health-care-pathways/)
- [Positive and negative predictive values](https://durgical.com/en/epidemiology/positive-and-negative-predictive-values/)

## Related conditions 7

- [Cervical cancer](https://durgical.com/en/conditions/cervical-cancer/)
- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)
- [Prostate cancer](https://durgical.com/en/conditions/prostate-cancer/)
- [Lung cancer](https://durgical.com/en/conditions/lung-cancer/)
- [Gastric cancer](https://durgical.com/en/conditions/gastric-cancer/)
- [Melanoma](https://durgical.com/en/conditions/melanoma/)

[← All of epidemiology](https://durgical.com/en/epidemiology/)

Educational content on epidemiological and statistical methods; the examples use made-up numbers to teach the calculation. Not a clinical or legal guide: current Colombian rules are in the official sources.

Sources: [Resolución 3280 de 2018: lineamientos técnicos y operativos de la Ruta de Promoción y Mantenimiento de la Salud (compiled text with the changes of Resolución 276 de 2019)](https://jurinfo.jep.gov.co/Normograma/Compilacion/docs/resolucion_minsaludps_3280_2018.htm) (Ministerio de Salud y Protección Social de Colombia (compiled text, JEP normograma), 2018); [Guía de práctica clínica para la detección temprana, diagnóstico, estadificación y tratamiento del cáncer de pulmón. Guía para profesionales de la salud (GPC 2014-36)](https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/CA/gpc-cancer-pulmon-profesionales.pdf) (Ministerio de Salud y Protección Social – Colciencias, 2014); [Prostate Cancer: Screening. Final Recommendation Statement](https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening) (U.S. Preventive Services Task Force, 2018); [Incidence and mortality by cancer in the Pasto municipality, Colombia. 2013-2017](https://doi.org/10.25100/cm.v53i1.4952) (Colombia Médica, 2022).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/epidemiology/cancer-screening-in-adults-by-site-what-colombia-offers/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/epidemiology/cancer-screening-in-adults-by-site-what-colombia-offers/
